First Trust Health Care AlphaDEX Fund Rating $114.78 0.00 (0.00%) Closing price 05/22/2026 04:10 PM EasternExtended Trading$114.78 0.00 (0.00%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock First Trust Health Care AlphaDEX Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FXH Aggregate RatingHold 2.44Holdings in FXH have an aggregate rating of Hold based on 450 analyst ratings issued in the past year covering 25 companies (55.3% of the portfolio).FXH Aggregate Price Target$114.78High Prediction$114.78Average Prediction$114.78Low Prediction$114.78Holdings in FXH have an aggregate price target of $114.78 and a range of $114.78 to $114.78 covering 25 companies (55.3% of the portfolio).FXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Health Care AlphaDEX Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FXH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.83%OGNOrganon & Co.$13.44+0.0%2.9537 of 5 stars1.71$11.40 -15.1%73.73%HUMHumana$307.79-0.1%3.3329 of 5 stars2.18$263.35 -14.4%28Positive NewsAnalyst Forecast2.91%ELVElevance Health$394.41-0.1%4.3799 of 5 stars2.61$399.32 1.2%23Positive NewsAnalyst Forecast2.69%DVADaVita$198.39-0.1%3.2258 of 5 stars2.38$199.17 0.4%82.56%EXELExelixis$50.152.3955 of 5 stars2.39$47.35 -5.6%23Insider Trade2.45%SOLVSolventum$76.92+0.1%3.0576 of 5 stars2.50$84.25 9.5%142.41%MOHMolina Healthcare$184.080.0%2.2775 of 5 stars2.06$176.00 -4.4%16Positive NewsAnalyst Forecast2.37%CICigna Group$286.06-0.1%4.9469 of 5 stars2.81$339.80 18.8%21Positive NewsAnalyst Forecast2.24%BIIBBiogen$193.763.8302 of 5 stars2.52$215.62 11.3%292.23%INCYIncyte$97.164.6313 of 5 stars2.41$104.00 7.0%22Positive News2.05%UHSUniversal Health Services$157.61-0.1%4.5875 of 5 stars2.28$221.56 40.6%18Gap Up1.98%REGNRegeneron Pharmaceuticals$638.884.6352 of 5 stars2.70$792.65 24.1%271.97%CAHCardinal Health$200.42-0.1%4.8052 of 5 stars2.94$241.80 20.6%18Positive News1.96%ZBHZimmer Biomet$85.41-0.1%4.4671 of 5 stars2.26$102.80 20.4%23Dividend Announcement1.96%HCAHCA Healthcare$394.40+0.1%4.7813 of 5 stars2.63$515.77 30.8%241.94%CHEChemed$439.70+0.1%4.0308 of 5 stars2.33$501.50 14.1%6Dividend AnnouncementAnalyst Downgrade1.92%GMEDGlobus Medical$84.84+0.0%4.7127 of 5 stars2.81$106.36 25.4%16Analyst Revision1.90%EHCEncompass Health$105.04+0.1%4.5387 of 5 stars3.11$145.29 38.3%9Positive NewsAnalyst Forecast1.90%BIOBio-Rad Laboratories$288.55+0.3%1.2372 of 5 stars2.00$303.33 5.1%5Analyst Revision1.81%THCTenet Healthcare$174.00+0.1%4.6722 of 5 stars2.86$244.16 40.3%22Gap Up1.73%IONSIonis Pharmaceuticals$75.563.4789 of 5 stars2.90$100.90 33.5%211.72%MASIMasimo$178.811.1463 of 5 stars2.00$180.40 0.9%91.69%PENPenumbra$328.46-0.1%3.6195 of 5 stars2.18$361.33 10.0%17Positive News1.67%UTHRUnited Therapeutics$568.433.9285 of 5 stars2.85$619.42 9.0%13Insider Trade1.64%AMGNAmgen$339.304.1698 of 5 stars2.48$355.19 4.7%31Positive NewsAnalyst Upgrade This page (NYSEARCA:FXH) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Health Care AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Health Care AlphaDEX Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
